Steward Partners Investment Advisory, LLC Gilead Sciences, Inc. Transaction History

Steward Partners Investment Advisory, LLC

$9.37 Billion
Q2 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 35,416 shares of GILD stock, worth $2.97 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

35,416

Previous 35,199 0.62%

Holding current value

$2.97 Million

Previous $2.58 Million 5.78%

% of portfolio

0.03%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$63.15 - $72.88 $13,703 - $15,814	217 Added 0.62%	35,416 $2.43 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $217,889 - $265,710	3,044 Added 9.47%	35,199 $2.58 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $47,698 - $54,091	651 Added 2.07%	32,155 $2.6 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $225,886 - $246,446	3,055 Added 10.74%	31,504 $2.36 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $16,038 - $18,293	-211 Reduced 0.74%	28,449 $2.19 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $25,357 - $28,890	328 Added 1.16%	28,660 $2.38 Million
Q4 2022 Feb 15, 2023	SELL	$62.32 - $89.47 $71,792 - $103,069	-1,152 Reduced 3.91%	28,332 $2.43 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $55,967 - $63,929	940 Added 3.29%	29,484 $1.82 Million
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $24,242 - $27,304	-420 Reduced 1.45%	28,544 $1.76 Million
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $908,591 - $1.14 Million	-15,687 Reduced 35.13%	28,964 $1.72 Million
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $2.62 Million - $2.97 Million	-40,340 Reduced 47.46%	44,651 $3.24 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $515,933 - $556,634	7,622 Added 9.85%	84,991 $5.94 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $584,114 - $638,228	9,203 Added 13.5%	77,369 $5.33 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $297,660 - $339,630	-4,961 Reduced 6.78%	68,166 $4.41 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $1.59 Million - $1.81 Million	-27,993 Reduced 27.68%	73,127 $4.26 Million
Q3 2020 Oct 30, 2020	BUY	$62.1 - $78.08 $196,546 - $247,123	3,165 Added 3.23%	101,120 $6.39 Million
Q2 2020 Aug 06, 2020	BUY	$72.34 - $84.0 $302,815 - $351,624	4,186 Added 4.46%	97,955 $7.54 Million
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $891,037 - $1.14 Million	14,227 Added 17.89%	93,769 $7.01 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $28,653 - $31,517	-465 Reduced 0.58%	79,542 $5.17 Million
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $2.59 Million - $2.86 Million	41,487 Added 107.7%	80,007 $5.07 Million
Q2 2019 Jul 25, 2019	BUY	$61.87 - $69.38 $548,477 - $615,053	8,865 Added 29.89%	38,520 $2.6 Million
Q1 2019 Apr 30, 2019	BUY	$62.53 - $70.05 $31,952 - $35,795	511 Added 1.75%	29,655 $1.93 Million
Q4 2018 Jan 15, 2019	SELL	$60.54 - $79.0 $9,081 - $11,850	-150 Reduced 0.51%	29,144 $1.82 Million
Q3 2018 Oct 23, 2018	SELL	$71.28 - $78.92 $45,975 - $50,903	-645 Reduced 2.15%	29,294 $2.26 Million
Q2 2018 Jul 20, 2018	BUY	$64.88 - $75.68 $139,492 - $162,712	2,150 Added 7.74%	29,939 $2.12 Million
Q1 2018 Apr 20, 2018	BUY	$72.84 - $88.8 $159,009 - $193,850	2,183 Added 8.53%	27,789 $2.1 Million
Q4 2017 Jan 19, 2018	BUY	$71.15 - $83.52 $672,225 - $789,096	9,448 Added 58.47%	25,606 $1.83 Million
Q3 2017 Nov 22, 2017	BUY	$72.11 - $85.47 $154,675 - $183,333	2,145 Added 15.31%	16,158 $1.31 Million
Q2 2017 Nov 22, 2017	SELL	N/A	-8,715 Reduced 38.34%	14,013 $991,000
Q1 2017 Nov 22, 2017	BUY	N/A	19,138 Added 533.09%	22,728 $1.54 Million
Q4 2016 Nov 22, 2017	BUY	N/A	3,590	3,590 $257,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Gilead Sciences, Inc. Transaction History